Olanzapine (Zypine ODT) 10 mg orodispersible tablets: Supply issue
The supplier will run out of the 10 mg orodispersible olanzapine tablets (Pharmacode: 2439840) by the end of February 2026.
Affected product
Due to manufacturing and shipping delays, the supplier expects to run out of olanzapine orodispersible tablets before the next shipment arrives.
- Chemical: Olanzapine
- Presentation: Tab orodispersible 10 mg
- Brand: Zypine ODT
- Pharmacode: 2439840
- Subsidy: $2.89
- Measure / Qty: per 28
Schedule listing for olanzapine(external link)
Please note the 10 mg tablets were affected by an out of stock until early February.
Alternative brands
From 1 March 2026, we are funding two alternative brands of olanzapine orodispersible tablets. They are not Medsafe approved and will need to be prescribed and dispensed in line with section 29A of the Medicines Act.
The alternatives are the same formulation as the Zypine brand and the tablets look the same. While the tablets are the same, they are labelled for other countries, Italy and Poland. They are supplied by the same company, Viatris.
Viatris will be putting an English label on the boxes, however the blister packs will still have the original Italian or Polish labelling, pictured.
Olanzapine with Italian label
- Brand: Olanzapina Mylan Pharma
- Presentation: Tab orodispersible 10 mg
- Pharmacode: 2724227
- Subsidy: $2.89
- Measure / Qty: 28
Olanzapine with Polish label
- Brand: Olanzapina Mylan
- Presentation: Tab orodispersible 10 mg
- Pharmacode: 2724235
- Subsidy: $2.89
- Measure / Qty: per 28
Where 10 mg tablets are unavailable
We have received clinical advice that people can receive two x 5 mg tablets where 10 mg tablets are not available.
Prescribing and supplying an unapproved medicine
Section 29A of the Medicines Act 1981 allows for medicines that are not Medsafe approved to be prescribed and supplied to people.
We know supplying an unapproved medicine. In this case, however, this will allow people to continue to access an appropriate treatment.
We apologise for any inconvenience this causes.
What patients need to know about unapproved medicines – Healthify website(external link)
Expected resupply
The supplier expects Zypine ODT to arrive early March 2026. It will take another 1 to 2 weeks to reach pharmacies around the country.
Who to contact
If you have questions about this issue, email enquiry@pharmac.govt.nz
Please include as much information as you can about the product (presentation, brand, pharmacode) and who your wholesaler is.
Sign up to our email list for regular emails about supply issues and more(external link)